{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T04:50:52Z","timestamp":1783831852751,"version":"3.55.0"},"reference-count":51,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The exploitation of bioactive natural sources to obtain new anticancer agents with novel modes of action may represent an innovative and successful strategy in the field of medicinal chemistry. Many natural products and their chemical analogues have been proposed as starting molecules to synthesise compounds with increased biological potential. In this work, the design, synthesis, and characterisation of a new series of N4,N4-dimethylated thiosemicarbazone Cu(II), Ni(II), and Pt(II) complexes are reported and investigated for their in vitro toxicological profile against a leukaemia cell line (U937). The antiproliferative activity was studied by MTS assay to determine the GI50 value for each compound after 24 h of treatment, while the genotoxic potential was investigated to determine if the complexes could cause DNA damage. In addition, the interaction between the synthesised molecules and DNA was explored by means of spectroscopic techniques, showing that for Pt and Ni derivatives a single mode of action can be postulated, while the Cu analogue behaves differently.<\/jats:p>","DOI":"10.3390\/molecules28062778","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T03:30:31Z","timestamp":1679283031000},"page":"2778","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antiproliferative Activity and DNA Interaction Studies of a Series of N4,N4-Dimethylated Thiosemicarbazone Derivatives"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2316-7159","authenticated-orcid":false,"given":"Serena","family":"Montalbano","sequence":"first","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area Delle Scienze 11\/A, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9877-2767","authenticated-orcid":false,"given":"Annamaria","family":"Buschini","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area Delle Scienze 11\/A, 43124 Parma, Italy"},{"name":"COMT (Interdepartmental Centre for Molecular and Translational Oncology), University of Parma, Parco Area Delle Scienze 11\/A, 43124 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pelosi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area Delle Scienze 11\/A, 43124 Parma, Italy"},{"name":"COMT (Interdepartmental Centre for Molecular and Translational Oncology), University of Parma, Parco Area Delle Scienze 11\/A, 43124 Parma, Italy"},{"name":"CERT (Center of Excellence for Toxicological Research), University of Parma, via Gramsci 14, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9165-0356","authenticated-orcid":false,"given":"Franco","family":"Bisceglie","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parco Area Delle Scienze 11\/A, 43124 Parma, Italy"},{"name":"COMT (Interdepartmental Centre for Molecular and Translational Oncology), University of Parma, Parco Area Delle Scienze 11\/A, 43124 Parma, Italy"},{"name":"CERT (Center of Excellence for Toxicological Research), University of Parma, via Gramsci 14, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bonaccorso, C., Marzo, T., and La Mendola, D. (2019). Biological Applications of Thiocarbohydrazones and Their Metal Complexes: A Perspective Review. Pharmaceuticals, 13.","DOI":"10.3390\/ph13010004"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejmech.2019.03.024","article-title":"Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues","volume":"170","author":"Leite","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1089\/ars.2017.7487","article-title":"Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development","volume":"30","author":"Heffeter","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.saa.2014.02.141","article-title":"Synthesis, spectroscopic, anticancer and antibacterial studies of Ni(II) and Cu(II) complexes with 2-carboxybenzaldehyde thiosemicarbazone","volume":"129","author":"Chandra","year":"2014","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111786","DOI":"10.1016\/j.jinorgbio.2022.111786","article-title":"The coordination modes of (thio)semicarbazone copper(II) complexes strongly modulate the solution chemical properties and mechanism of anticancer activity","volume":"231","author":"Hajdu","year":"2022","journal-title":"J. Inorg. Biochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1874846501003020016","article-title":"Thiosemicarbazone Metal Complexes: From Structure to Activity","volume":"3","author":"Pelosi","year":"2010","journal-title":"Open Crystallogr. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.arabjc.2015.08.013","article-title":"Synthesis, structural elucidation and cytotoxicity of new thiosemicarbazone derivatives","volume":"12","author":"Hussein","year":"2019","journal-title":"Arab. J. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"107778","DOI":"10.1016\/j.intimp.2021.107778","article-title":"Therapeutic perspective of thiosemicarbazones derivatives in inflammatory pathologies: A summary of in vitro\/in vivo studies","volume":"96","author":"Kanso","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Milunovi\u0107, M.N.M., Palamarciuc, O., Sirbu, A., Shova, S., Dumitrescu, D., Dvoranov\u00e1, D., Rapta, P., Petrasheuskaya, T.V., Enyedy, E.A., and Spengler, G. (2020). Insight into the Anticancer Activity of Copper(II) 5-Methylenetrimethylammonium-Thiosemicarbazonates and Their Interaction with Organic Cation Transporters. Biomolecules, 10.","DOI":"10.3390\/biom10091213"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Montalbano, S., Degola, F., Bartoli, J., Bisceglie, F., Buschini, A., Carcelli, M., Feretti, D., Galati, S., Marchi, L., and Orsoni, N. (2021). The AFLATOX\u00ae Project: Approaching the Development of New Generation, Natural-Based Compounds for the Containment of the Mycotoxigenic Phytopathogen Aspergillus flavus and Aflatoxin Contamination. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094520"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11214","DOI":"10.1038\/s41598-017-11716-w","article-title":"Thiosemicarbazone scaffold for the design of antifungal and antiaflatoxigenic agents: Evaluation of ligands and related copper complexes","volume":"7","author":"Rogolino","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1573406417666210803170637","article-title":"Synthesis of a Series of Novel 2-Amino-5-Substituted 1,3,4-oxadiazole and 1,3,4-thiadiazole Derivatives as Potential Anticancer, Antifungal and Antibacterial Agents","volume":"18","author":"Pham","year":"2021","journal-title":"Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"131166","DOI":"10.1016\/j.molstruc.2021.131166","article-title":"The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2","volume":"1246","author":"Kaya","year":"2021","journal-title":"J. Mol. Struct."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"104081","DOI":"10.1016\/j.bioorg.2020.104081","article-title":"Syntheses, quantum mechanical modeling, biomolecular interaction and in vitro anticancer\u2014Tubulin activity of thiosemicarbazones","volume":"102","author":"Xavier","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1039\/C9MD00594C","article-title":"Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias","volume":"11","author":"Sun","year":"2020","journal-title":"RSC Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116107","DOI":"10.1016\/j.bmc.2021.116107","article-title":"Synthesis and evaluation of novel thiosemicarbazone and semicarbazone analogs with both anti-proliferative and anti-metastatic activities against triple negative breast cancer","volume":"37","author":"Bai","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1039\/C6DT02784A","article-title":"Structure-antiproliferative activity studies on l-proline- and homoproline-4-N-pyrrolidine-3-thiosemicarbazone hybrids and their nickel(ii), palladium(ii) and copper(ii) complexes","volume":"45","author":"Dobrova","year":"2016","journal-title":"Dalton Trans."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jinorgbio.2008.12.016","article-title":"Synthesis, characterization and deepening in the comprehension of the biological action mechanisms of a new nickel complex with antiproliferative activity","volume":"103","author":"Buschini","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1039\/c3mt00345k","article-title":"Unravelling mechanisms behind the biological activity of bis(S-citronellalthiosemicarbazonato)nickel(II)","volume":"6","author":"Buschini","year":"2014","journal-title":"Metallomics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1039\/c9mt00166b","article-title":"Cytotoxic activity of copper(ii), nickel(ii) and platinum(ii) thiosemicarbazone derivatives: Interaction with DNA and the H2A histone peptide","volume":"11","author":"Bisceglie","year":"2019","journal-title":"Metallomics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1038\/s41598-020-67439-y","article-title":"Mechanistic insights on the mode of action of an antiproliferative thiosemicarbazone-nickel complex revealed by an integrated chemogenomic profiling study","volume":"10","author":"Baruffini","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jinorgbio.2017.11.009","article-title":"Effects of polar substituents on the biological activity of thiosemicarbazone metal complexes","volume":"179","author":"Bisceglie","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinorgbio.2014.07.014","article-title":"Cinnamaldehyde and cuminaldehyde thiosemicarbazones and their copper(II) and nickel(II) complexes: A study to understand their biological activity","volume":"140","author":"Bisceglie","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1039\/c3mt00127j","article-title":"Ni(II) and Cu(II) N(4)-ethylmorpholine citronellalthiosemicarbazonate: A comparative analysis of cytotoxic effects in malignant human cancer cell lines","volume":"5","author":"Bisceglie","year":"2013","journal-title":"Metallomics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jinorgbio.2012.07.006","article-title":"Copper(II) thiosemicarbazonate molecular modifications modulate apoptotic and oxidative effects on U937 cell line","volume":"116","author":"Bisceglie","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1039\/D0DT01133A","article-title":"Novel tetranuclear PdII and PtII anticancer complexes derived from pyrene thiosemicarbazones","volume":"49","author":"Oliveira","year":"2020","journal-title":"Dalton Trans."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jinorgbio.2014.03.004","article-title":"Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: Syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity","volume":"136","author":"Shao","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"110931","DOI":"10.1016\/j.jinorgbio.2019.110931","article-title":"Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies","volume":"203","author":"Bermejo","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"110907","DOI":"10.1016\/j.jinorgbio.2019.110907","article-title":"Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligand","volume":"203","author":"Beebe","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ha\u0142dys, K., Goldeman, W., Anger-G\u00f3ra, N., Rossowska, J., and Latajka, R. (2021). Monosubstituted Acetophenone Thiosemicarbazones as Potent Inhibitors of Tyrosinase: Synthesis, Inhibitory Studies, and Molecular Docking. Pharmaceuticals, 14.","DOI":"10.3390\/ph14010074"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1021\/acsmedchemlett.7b00186","article-title":"Structure-Based Discovery of Thiosemicarbazone Metalloproteinase Inhibitors for Hemorrhage Treatment in Snakebites","volume":"8","author":"Ferreira","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jinorgbio.2018.02.014","article-title":"Nickel(II) bis(isatin thiosemicarbazone) complexes induced apoptosis through mitochondrial signaling pathway and G0\/G1 cell cycle arrest in IM-9 cells","volume":"182","author":"Balachandran","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0006-2952(99)00419-0","article-title":"Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity","volume":"59","author":"Finch","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.leukres.2007.01.004","article-title":"Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies","volume":"31","author":"Gojo","year":"2007","journal-title":"Leuk. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/annonc\/mdn775","article-title":"Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma","volume":"20","author":"Nutting","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/OTT.S196347","article-title":"Ribonucleotide reductase subunit M2 as a novel target for clear-cell renal cell carcinoma","volume":"12","author":"Zou","year":"2019","journal-title":"Onco Targets Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fonc.2019.01067","article-title":"Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers","volume":"9","author":"Kunos","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10637-012-9863-1","article-title":"A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors","volume":"31","author":"Mortazavi","year":"2013","journal-title":"Invest. New Drugs"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10637-008-9115-6","article-title":"Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia","volume":"26","author":"Odenike","year":"2008","journal-title":"Invest. New Drugs"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00280-008-0890-8","article-title":"A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors","volume":"63","author":"Schelman","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00280-010-1250-z","article-title":"The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors","volume":"66","author":"Choi","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fonc.2014.00184","article-title":"Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer","volume":"4","author":"Kunos","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1021\/bi00394a013","article-title":"Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA","volume":"26","author":"Wolfe","year":"1987","journal-title":"Biochemistry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.jinorgbio.2004.04.019","article-title":"Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding","volume":"98","author":"Kasparkova","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0301-4622(90)80003-P","article-title":"Biophysical studies of the modification of DNA by antitumour platinum coordination complexes","volume":"35","author":"Brabec","year":"1990","journal-title":"Biophys. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zeng, W., Zhang, Y., Zheng, W., Luo, Q., Han, J., Liu, J., Zhao, Y., Jia, F., Wu, K., and Wang, F. (2019). Discovery of Cisplatin Binding to Thymine and Cytosine on a Single-Stranded Oligodeoxynucleotide by High Resolution FT-ICR Mass Spectrometry. Molecules, 24.","DOI":"10.3390\/molecules24101852"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/15384047.2016.1235658","article-title":"Chk1 and DNA-PK mediate TPEN-induced DNA damage in a ROS dependent manner in human colon cancer cells","volume":"17","author":"Rahal","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0162-0134(02)00428-2","article-title":"Synthesis, characterization and X-ray structures of new antiproliferative and proapoptotic natural aldehyde thiosemicarbazones and their nickel(II) and copper(II) complexes","volume":"90","author":"Bisceglie","year":"2002","journal-title":"J. Inorg. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/ja01640a067","article-title":"A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic Acid","volume":"76","author":"Reichmann","year":"1954","journal-title":"J. Am. Chem. Soc."},{"key":"ref_51","unstructured":"Fox, K.R. (1997). Methods in Molecular Biology, Humana."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/6\/2778\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:58:57Z","timestamp":1760122737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/6\/2778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["molecules28062778"],"URL":"https:\/\/doi.org\/10.3390\/molecules28062778","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}